TABLE 2—
Initiation of Use of Long-Acting Reversible Contraceptive (LARC), by Study Arm and Funding Source (n = 1478): United States, February 2011–May 2013
| Hazard Ratio (95% CI) |
|||
| Variable | No. (Rate/100 PY) | Model 1 | Model 2 |
| Study arm | |||
| Control | 111 (18.1) | 1 (Ref) | 1 (Ref) |
| Intervention | 162 (21.9) | 1.43 (1.04, 1.98) | 1.44 (1.03, 2.01) |
| Medicaid family planning expansion | |||
| No | 68 (13.5) | 1 (Ref) | 1 (Ref) |
| Yes | 205 (24.6) | 2.26 (1.59, 3.19) | 2.21 (1.55, 3.16) |
| Health insurance | |||
| None | 86 (16.7) | … | 1 (Ref) |
| Private | 64 (15.8) | … | 1.06 (0.75, 1.49) |
| Public | 110 (30.2) | … | 1.56 (1.09, 2.22) |
| Don’t know | 10 (15.8) | … | 1.03 (0.53, 2.01) |
Note. CI = confidence interval; PY = person-years. Models included age, race/ethnicity, parity, public assistance, primary sexual partner, LARC use in 3 months prior to enrollment, pregnancy attitude, and visit type.